123 related articles for article (PubMed ID: 20037359)
1. [Two radically resected colorectal carcinoma cases with unresectable liver metastasis after adjuvant chemotherapy with bevacizumab].
Sugiyama M; Kakeji Y; Kubo N; Nakanoko T; Fujinaka Y; Ando K; Masuda T; Yagi K; Yoshinaga K; Saeki H; Endo K; Emi Y; Morita M; Maehara Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2169-71. PubMed ID: 20037359
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S;
Oncology; 2013; 84(1):14-21. PubMed ID: 23076023
[TBL] [Abstract][Full Text] [Related]
3. Recurrent disease four years after surgery and adjuvant chemotherapy.
Pozzo C; Barone C
Cancer Treat Rev; 2008; 34 Suppl 2():S8-11. PubMed ID: 19101406
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.
Klinger M; Eipeldauer S; Hacker S; Herberger B; Tamandl D; Dorfmeister M; Koelblinger C; Gruenberger B; Gruenberger T
Eur J Surg Oncol; 2009 May; 35(5):515-20. PubMed ID: 19200687
[TBL] [Abstract][Full Text] [Related]
5. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.
Aussilhou B; Dokmak S; Faivre S; Paradis V; Vilgrain V; Belghiti J
Ann Surg Oncol; 2009 Jun; 16(6):1553-9. PubMed ID: 19363584
[TBL] [Abstract][Full Text] [Related]
6. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.
Tamandl D; Gruenberger B; Klinger M; Herberger B; Kaczirek K; Fleischmann E; Gruenberger T
Ann Surg; 2010 Jul; 252(1):124-30. PubMed ID: 20562613
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.
Klinger M; Tamandl D; Eipeldauer S; Hacker S; Herberger B; Kaczirek K; Dorfmeister M; Gruenberger B; Gruenberger T
Ann Surg Oncol; 2010 Aug; 17(8):2059-65. PubMed ID: 20177795
[TBL] [Abstract][Full Text] [Related]
8. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
D'Angelica M; Kornprat P; Gonen M; Chung KY; Jarnagin WR; DeMatteo RP; Fong Y; Kemeny N; Blumgart LH; Saltz LB
Ann Surg Oncol; 2007 Feb; 14(2):759-65. PubMed ID: 17103075
[TBL] [Abstract][Full Text] [Related]
9. [A case of pathological complete response of metachronous multiple liver metastases from colorectal cancer after mFOLFOX+bevacizumab chemotherapy].
Otsuka S; Inagaki M; Nishie M; Hamano R; Tokunaga N; Takahashi K; Tsunemitsu Y; Miyoshi K; Iwakawa K; Takahashi M; Iwagak H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2166-8. PubMed ID: 20037358
[TBL] [Abstract][Full Text] [Related]
10. [Repeated resections for originally unresectable liver metastasis from colorectal cancer after multiagent chemotherapy].
Kobayashi H; Uetake H; Higuchi T; Enomoto M; Iida S; Ishikawa T; Ishiguro M; Kato S; Matsuyama T; Ono H; Yamauchi S; Masuda D; Sugihara K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2301-3. PubMed ID: 22202362
[TBL] [Abstract][Full Text] [Related]
11. Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases--newer multimodality approach.
Lygidakis NJ; Bhagat AD; Vrachnos P; Grigorakos L
Hepatogastroenterology; 2007 Jun; 54(76):1020-4. PubMed ID: 17629030
[TBL] [Abstract][Full Text] [Related]
12. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.
Murthy R; Eng C; Krishnan S; Madoff DC; Habbu A; Canet S; Hicks ME
J Vasc Interv Radiol; 2007 Dec; 18(12):1588-91. PubMed ID: 18057297
[TBL] [Abstract][Full Text] [Related]
13. [A case of unresectable multiple liver metastases of colorectal cancer in which ALTA(ZION), used to control internal hemorrhoidal bleeding, enabled administration of bevacizumab].
Kato K; Otsuka K; Kato N; Itabashi T; Akiyama Y; Wakabayashi G
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1553-5. PubMed ID: 24231714
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
15. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
Yoo PS; Lopez-Soler RI; Longo WE; Cha CH
Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.
Ganapathi AM; Westmoreland T; Tyler D; Mantyh CR
J Am Coll Surg; 2012 Apr; 214(4):582-8; discussion 588-90. PubMed ID: 22321523
[TBL] [Abstract][Full Text] [Related]
17. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases.
Wicherts DA; de Haas RJ; Sebagh M; Saenz Corrales E; Gorden DL; Lévi F; Paule B; Azoulay D; Castaing D; Adam R
Br J Surg; 2011 Mar; 98(3):399-407. PubMed ID: 21254017
[TBL] [Abstract][Full Text] [Related]
18. Curing patients with liver metastases from colorectal cancer.
Drug Ther Bull; 2011 Apr; 49(4):42-5; quiz i-ii. PubMed ID: 21467575
[TBL] [Abstract][Full Text] [Related]
19. [Two-stage hepatectomy combined with converting chemotherapy achieved a successful treatment for initially unresectable multiple bilobar colorectal liver metastases].
Ueda A; Yoshidome H; Kagawa S; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Kuboki S; Miyazaki M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2557-9. PubMed ID: 21224638
[TBL] [Abstract][Full Text] [Related]
20. Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor.
Kornprat P; Schöllnast H; Cerwenka H; Werkgartner G; Bernhardt G; Mischinger HJ
Int J Colorectal Dis; 2009 Jan; 24(1):125-6. PubMed ID: 18682963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
